Clinical Trial Update: Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study [Phase 4]

View source ↗

Summary

A Phase 4 add-on study evaluating fenfuro (fenugreek seed extract) in subjects with type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Fenfuro (fenugreek seed extract)

Snippet

Sponsor: Chemical Resources | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED